REGENXBIO, Inc. (RGNX)
6.69
+0.38
(+6.02%)
USD |
NASDAQ |
May 27, 16:00
6.69
0.00 (0.00%)
After-Hours: 16:34
REGENXBIO Cash from Investing (Quarterly) : 70.59M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| AbbVie, Inc. | -574.00M |
| Ocugen, Inc. | -0.006M |
| Replimune Group, Inc. | 75.12M |
| Sarepta Therapeutics, Inc. | -134.39M |
| Krystal Biotech, Inc. | -63.58M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -76.19M |
| Cash from Financing (Quarterly) | -13.64M |
| Free Cash Flow | -236.40M |
| Free Cash Flow Per Share (Quarterly) | -1.477 |
| Free Cash Flow to Equity (Quarterly) | -65.30M |
| Free Cash Flow to Firm (Quarterly) | -68.71M |
| Free Cash Flow Yield | -68.17% |